The Importance of Correlation between Aldosterone and Parathyroid Hormone in Patients with Primary Hyperparathyroidism

Table 1

Clinical differences between the study and control group.

Variables	Study group PHPT (N = 48)	Control group (N = 30)
Age (years)	66 (52–72)	61 (54–68)	NS
Female (n/N) (%)	40 (83.3)	24 (80.0)	NS
Kidney stones (n/N)	12 (25.0)	3 (10.0)	0.001
Osteoporosis (n/N)	14 (29.2)	4 (13.3)	0.004
Hypertension (n/N) (%)	28 (58.3)	9 (30.0)	0.028
ACE inhibitors (n/N) (%)	10 (35.7)	4 (44.4)	NS
Diuretics (n/N) (%)	9 (32.1)	3 (33.3)	NS
Beta blockers (n/N) (%)	11 (39.3)	4 (44.4)	NS

Normally distributed variables presented as x ± SD and skewed variables by median (interquartile range); categorical variables presented as n (%); NS—not significant; PHPT—Primary hyperparathyroidism; ACE—angiotensin converting enzyme.